sr141716 has been researched along with thymidine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Díaz-Laviada, I; Ruiz-Llorente, L; Sánchez, AM; Sánchez, MG | 1 |
Auchampach, JA; Carrier, EJ; Hillard, CJ | 1 |
2 other study(ies) available for sr141716 and thymidine
Article | Year |
---|---|
Enhancement of androgen receptor expression induced by (R)-methanandamide in prostate LNCaP cells.
Topics: Androgen Receptor Antagonists; Arachidonic Acids; Cannabinoids; Cell Division; Cell Line, Tumor; DNA, Neoplasm; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Male; Mitogens; Phosphoinositide-3 Kinase Inhibitors; Piperidines; Prostatic Neoplasms; Pyrazoles; Receptors, Androgen; Rimonabant; Thymidine; Tritium; Up-Regulation | 2003 |
Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression.
Topics: Adenosine; Animals; Camphanes; Cannabidiol; Cell Line; Cell Proliferation; DNA; Dronabinol; Equilibrative Nucleoside Transporter 1; Immunosuppression Therapy; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microglia; Nucleoside Transport Proteins; Piperidines; Psychotropic Drugs; Pyrazoles; Rimonabant; Thymidine; Tumor Necrosis Factor-alpha | 2006 |